Tag: Motley Fool

The Bendigo and Adelaide Bank Ltd (ASX: BEN) share price is pushing higher in early trade despite no new announcements from the Aussie bank. This comes after rival Xinja announced its retreat from the neobank market.

Why the Bendigo and Adelaide Bank share price is on the rise

The big news today impacting the Bendigo and Adelaide Bank share price actually doesn’t come from Bendigo itself. However, one of its key neobank rivals has announced it will turn in its authorised deposit-taking institution (ADI) license and return capital to its members.

Xinja has today announced it will hand back its banking license after market pressures made the business unviable. The Aussie neobank burst onto the scene with high savings rates but no lending product in the market.

That has seen significant cash burn to pay out its account holders without any money coming in the door from lending activities. That’s despite the Australian Prudential Regulation Authority (APRA) granting Xinja the license in September 2019.

So, what does this have to do with Bendigo? The Bendigo and Adelaide Bank share price is charging higher thanks to broad market positivity and its status as a neobank competitor.

Bendigo is a key partner and collaborator in Up, another Aussie neobank founded in 2018. That means the retreat of Xinja could strengthen Up’s position in the increasingly-saturated neobank market.

It’s a similar story for National Australia Bank Ltd (ASX: NAB), which has its own neobank product via its UBank division.

The Bendigo and Adelaide Bank share price has pushed 1.2% higher in early trade while NAB shares are up 1.8% to start the day. It’s good news across most of the financial services sector with Commonwealth Bank of Australia (ASX: CBA) shares also climbing after the company announced a merger between Aussie Home Loans and Lendi.

The S&P/ASX 200 Index (ASX: XJO) has pushed 1.0% higher to nearly 6,700 points thanks to a strong performance on Wall Street overnight.

More reading

• The ASX bank with the best dividend yield under APRA’s new guidelines
• Here’s how ASX 200 bank shares have performed in 2020 so far
• Why ASX banks are licking their lips right now
• ASX 200 falls on Tuesday
• Here are the US shares ASX investors are buying

Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why the Bendigo and Adelaide Bank (ASX:BEN) share price is jumping higher today appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/38anNGr

The Global Health Limited (ASX: GLH) share price is lifting higher today after the company announced it was experiencing strong demand for its Lifecard Patient Portal. At the time of writing, the Global Health share price is up 1.12% at 45 cents.

Global Health is an Australia-based company that develops, sells and supports the application software for the healthcare sector. The business also integrates systems that allows electronic medical records, messages, and other services to be exchanged between healthcare professionals and the patient.

Robust demand for Lifecard Patient Portal

Today, Global Health advised that COVID-19 was driving unprecedented demand for digital healthcare engagement through its Lifecard Patient Portal.

The platform was soft-launched more than 3 years ago and deployed on 3 customer sites. Since March when the pandemic impacted everyday lives, Global Health installed the Lifecard Patient Portal on 12 other platforms. That has led the company to achieve a recurring revenue stream of more than $50,000 per month within 18 months.

Global Health noted that COVID-19 has accelerated demand for its products, as the population moves towards the digital healthcare space. In turn, the push into online systems gives accurate and up-to-date information from patients to medical professionals, thus improving efficiency and productivity.

Management commentary

Global Health managing director Matthew Cherian, said:

Global Health is constantly looking to enhance the doctor/patient experience and improve healthcare provider productivity and efficiency, while ensuring that patients do not get lost in administration and paperwork when seeking help for their health conditions and medical issues.

The additional cost of the Lifecard Patient Portal will generate immediate financial returns for our provider customers through time saved, reduced errors, and accurate patient health and financial information into Provider clinical systems. The bottom- line results are extremely compelling for healthcare providers.

Global Health share price performance

The Global Health share price reached a 52-week high of 60 cents last month. This came as the company announced that Western Australia had awarded a 10-year contract for MasterCare EMR.

Although, its shares have since dipped around 25%, the Global Health share price is up more than 200% for 2020.

More reading

• SelfWealth (ASX:SWF) share price higher on successful launch of US trading
• Want to make a million in the next market crash? I’d use these 3 Warren Buffett tips today
• Openpay (ASX: OPY) share price rockets up 8% after major announcement
• Why the Zoono (ASX:ZNO) share price is jumping 8% higher
• Althea (ASX:AGH) share price drops lower despite major announcement

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post The Global Health (ASX:GLH) share price is lifting today. Here’s why. appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/34gxuC2

SelfWealth Ltd (ASX: SWF) shares have been under pressure after slumping more than 30% from their 80 cent peak back in September. Despite its recent underperformance, the SelfWealth share price is still up more than 200% year to date at today’s prices.

This morning, SelfWealth shares are on the move again after the company announced the successful launch of its US trading functionality. In the opening minutes of trade, the SelfWealth share price has risen 3.7% to 56 cents. 

Plans for international trading 

SelfWealth previously announced its intentions to capture international trades in its FY20 first half results back in February 2020. The company hoped to capture international trades that investors were performing elsewhere. The service had an expected go live date of December 2020 and forecast 5,000 domestic clients to be trading US shares by June 2021. 

What’s driving the SelfWealth share price higher?

On 7 December, SelfWealth announced that US trading for its retail clients would be launching on schedule, on 14 December. 

Its existing 65,000+ active clients will now be able to submit a request to have the US trading feature added to each of their approved Australian equity portfolios. 

US trading features a USD cash account, competitive FX rates when transferring money between the AUD and USD cash accounts, low-cost and flat-fee brokerage of USD$9.50 per trade and the choice of over 7,500 US securities across all major US exchanges. 

Today, the SelfWealth share price is on the rise after the company revealed the uptake of the new service by its trading community has exceeded expectations. More than 7,000 active traders have requested the US trading feature be added to their SelfWealth portfolios in the nine days since the company announced pre registration on 7 December. 

Equally pleasing has been the increase in new account registrations since the US trading announcement on 7 December. This will continue to assist the company’s efforts of increasing customer acquisition into the new year. 

What did management say?

SelfWeath Managing Director Rob Edgley, commenting on the US trading launch had this to say:

To reach the milestone of more than 10% of SelfWealth’s existing customers registering for US trading in such a short amount of time is a significant achievement and many months ahead of our expectations.

More reading

• The Global Health (ASX:GLH) share price is lifting today. Here’s why.
• Want to make a million in the next market crash? I’d use these 3 Warren Buffett tips today
• Openpay (ASX: OPY) share price rockets up 8% after major announcement
• Why the Zoono (ASX:ZNO) share price is jumping 8% higher
• Althea (ASX:AGH) share price drops lower despite major announcement

Motley Fool contributor Lina Lim has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post SelfWealth (ASX:SWF) share price higher on successful launch of US trading appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3gPhSdU

Warren Buffett has previously invested money following a market crash to great effect. It has enabled him to buy high-quality companies at prices that undervalue their future prospects.

His strategy works because he is content to hold large amounts of cash ready to invest in a market decline. He also takes a long-term view of his investments, and seeks to buy businesses with wide economic moats.

Clearly, the timing of the next market crash is a known unknown. However, planning for it now could be a means of improving an investor’s prospects of making a million.

Warren Buffett’s willingness to hold cash

Warren Buffett holds a significantly greater proportion of cash within his portfolio than is often the case among other investors. Although this means lower returns when stock markets are rising, it provides him with the opportunity to capitalise on low valuations when they come along. And, with a market crash often being short in nature, having access to large amounts of liquidity can allow an investor to take advantage of temporarily cheap stock prices.

With interest rates currently at low levels, holding a substantial amount of cash may reduce an investor’s overall returns in the short run. However, the low valuations that are often available in a market decline may mean that it is worth accepting a lower return in the short run to obtain greater scope for capital appreciation over the long term.

A patient stance regarding the prospect of a market crash

Warren Buffett also takes a patient approach when managing his portfolio. This means that he is unconcerned about when a market crash will occur, or how long it will take for the stock market to recover. As a result, he is content to wait for the best opportunities to come along. Should they be unavailable at a particular point in time, he is happy to wait for shares in high-quality companies to trade at lower prices.

Looking ahead, it is unclear when the next market crash will occur. However, the past performance of the stock market suggests a downturn is always set to take place in the long run. Waiting for it to take place to buy high-quality stocks at cheap prices could be a profitable long-term move.

Seeking economic moats

Warren Buffett has previously purchased companies with wide economic moats. This is essentially a competitive advantage over their peers that can mean higher profits in a variety of market conditions. Through purchasing businesses with advantages such as strong customer loyalty and a unique product, it may be possible to generate relatively high returns in the next market crash.

Even if an investor matches the stock market’s long-term return of around 8% per year, a $100,000 investment today would become worth over a million within 30 years. However, by holding cash for better opportunities, having a patient approach and buying stocks with wide economic moats, it may be possible to obtain a higher return over the long run.

More reading

• The Global Health (ASX:GLH) share price is lifting today. Here’s why.
• SelfWealth (ASX:SWF) share price higher on successful launch of US trading
• Openpay (ASX: OPY) share price rockets up 8% after major announcement
• Why the Zoono (ASX:ZNO) share price is jumping 8% higher
• Althea (ASX:AGH) share price drops lower despite major announcement

Motley Fool contributor Peter Stephens has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Want to make a million in the next market crash? I’d use these 3 Warren Buffett tips today appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/34gX9L6

The Openpay Group Ltd (ASX: OPY) share price is surging up today after a major expansion announcement from the Aussie buy now, pay later (BNPL) group. At the time of writing, the Openpay share price is trading up 8.33% at $2.34.

Why is the Openpay share price rocketing up?

Openpay has marked its first full year of trading on the ASX by reporting a record trading result. The BNPL company posted a new record month of total transaction value (TTV) with November 2020 numbers skyrocketing.

November TTV totalled $35.7 million, up from the previous Openpay record of $25.8 million. Strong Black Friday and Cyber Monday sales provided a strong boost with Black Friday 2020 representing the best day of trading in Openpay’s history.

The Openpay share price has rocketed higher in the 12 months since listing with a market capitalisation of $150 million. Shares in the BNPL group are up 74.2% so far in 2020 with Openpay now boasting a $233.3 million valuation.

Openpay UK saw significant growth in active plans, up 1,919% on the prior corresponding period (pcp) with active customers up 961% on pcp in November. The group’s UK operations now has agreements in place with 53 merchants in a sign of further growth.

What else did Openpay announce?

The other big news alongside the record monthly trading result was the group’s expansion into the United States. Openpay has started its US launch with the appointment of highly respected US industry leaders.

Openpay’s focus and strategy remains the same as in Australia and the UK, with flexible longer-term and higher-value plans in its consumer and business to business (B2B) platforms.

Openpay has touted its strong management team and extensive deal pipeline as cornerstones of the US launch. That includes new Openpay US CEO and global chief strategy officer, Brian Shniderman. Mr Shniderman joins from Deloitte where he founded and grew the firm’s ‘globally top-ranked’ payments practice.

Foolish takeaway

The Openpay share price is one to watch this morning after the latest sales and expansion news, following in the footsteps of fellow BNPL rivals Zip Co Ltd (ASX: Z1P) and Afterpay Ltd (ASX: APT).

More reading

• ASX 200 falls on Tuesday
• Creso Pharma and Nuix were among the most traded shares on the ASX last week
• ASX 200 down 0.1%: APRA removes bank dividend restrictions, Fortescue slides, Zip higher
• Zip (ASX:Z1P) share price rises on Harvey Norman (ASX:HVN) partnership
• Why the Afterpay (ASX:APT) share price is not the only rising star this year

Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of ZIPCOLTD FPO. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Openpay (ASX: OPY) share price rockets up 8% after major announcement appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3oW3bst

The Zoono Group Ltd (ASX: ZNO) share price is among the best performers on the ASX this morning.

At the time of writing, the antimicrobial solutions provider’s shares are up 8% to $1.39.

What did Zoono announce?

This morning Zoono released an update on a number of company developments, including some large sales and distribution agreements.

One of those developments included testing of Zoono’s Z-71 Microbe Shield Surface Sanitiser by the Dubai Central Laboratory Department.

That test observed that there is a complete reduction of test bacteria (99.9%) on all provided material surfaces till 30 days from the initial coating, except in Rubber and Wood surfaces. The rubber and wood surface has some viable growth on the 30th day with a reduction of 90% test bacteria.

Additional testing undertaken by Intertek Caleb Brett in Dubai found a 100% reduction between the slide control recovery level and Zoono Z-71 recovery level at 24 hours, 7 days, and 30 days.

Following this comprehensive testing, Zoono has now received the Emirates Authority for Standardisation and Metrology (ESMA) Certificate of Conformity.

Supply agreements.

In light of this certification, the company has entered into a supply agreement with Fine Hygienic Paper in the Emirates and has received the initial NZ$1.5 million deposit against the first-year purchases.

The overall agreement is for five years and has minimum annual performance target volumes of NZ$21.5 million for the first 12 months. After which, it has target volumes of NZ$28.5 million in the second year, NZ$35.7 million in the third year, and then a 5% increase thereafter.

Zoono also revealed a three-year agreement in Russia with hygiene services company ECO-SALUS. By the end of the term, its volumes are expected to be a minimum of NZ$5 million a year.

New product launch.

A final development has been the launch of a new product, which management notes is diversifying its range of antimicrobial products.

The new product is a face mask treated with Zoono, protecting the wearer from pathogens over a period of time.

But this may not be the last product launch. Management advised that it continues to work with its globally recognised customers and distributors with the aim of developing new products to help them protect their staff, customers, and communities.

More reading

• Althea (ASX:AGH) share price drops lower despite major announcement
• Why the Pushpay (ASX:PPH) share price is tumbling lower today
• Why the Resolute Mining (ASX:RSG) share price is charging higher today
• The ASX bank with the best dividend yield under APRA’s new guidelines
• Why the Beacon Lighting (ASX:BLX) share price is on watch today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why the Zoono (ASX:ZNO) share price is jumping 8% higher appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3af6FST

The Althea Group Holdings Ltd (ASX: AGH) share price is out of form on Wednesday despite the release of a positive announcement.

In morning trade the cannabis company’s shares are down 2% to 49 cents.

Why is the Althea share price dropping lower?

Investors have been selling the company’s shares this morning despite it announcing that a major regulatory change has been confirmed in Australia. This change is in relation to the status of cannabidiol (CBD) in Australia.

According to the release, the Therapeutic Goods Administration (TGA) has issued its final decision on proposed amendments to the Poison Standard. These amendments will see a new Schedule 3 (Pharmacist Only Medicine) entry created for CBD.

The date of effect of the decision is 1 February 2021, which is much sooner than the original anticipated date of 1 June 2021.

What does this mean?

The amendment will allow CBD to be supplied for therapeutic use under a new Schedule 3 entry.

This new cannabis channel would allow Australian patients to purchase CBD products over the counter upon consultation with a pharmacist, without the need for a prescription.

In addition to this, the final decision includes a modification to the dose specified in the interim decision. It has been increased from 60 mg/day, up to 150 mg/day.

Althea believes the decision paves the way for its top selling full-spectrum CBD product, Althea CBD100, to be made available under Schedule 3. It is currently sold under Schedule 4, which makes it a Prescription Only Medicine.

Management commentary.

Althea’s CEO, Josh Fegan, commented: “We applaud the TGA’s final decision in this matter and are glad to see the administration listened to industry following the interim decision, and subsequently decided to increase the maximum recommended daily dose acknowledging that this dose is consistent with the expected safety profile of a Schedule 3 medicine.

“The final decision follows the Company’s announcement to shareholders that it had raised additional working capital, through an institutional placement, with a portion of those funds allocated towards the product development and registration of a range of CBD products for the potential Schedule 3 market in Australia. This decision provides confirmation of that marketplace and the Company can now proceed with its plans to have over the counter Althea products available for Australian patients in 2021,” he added.

More reading

• Cannabis share Althea (ASX:AGH) sinks 11% on capital raising and Aphria selldown
• Why Althea, Altium, Fortescue, & Retail Food Group are dropping lower
• Why cannabis company Althea (ASX:AGH) is storming higher today
• Althea (ASX:AGH) share price lifts 10% today. Here’s why
• Why the Althea (ASX:AGH) share price soared 6% today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Althea (ASX:AGH) share price drops lower despite major announcement appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3qW3vtb

The Pushpay Holdings Ltd (ASX: PPH) share price has returned from its trading halt and is tumbling lower.

At the time of writing, the donor management and engagement platform provider’s shares are down 3.5% to $1.72.

Why was the Pushpay share price in a trading halt?

On Tuesday, Pushpay requested a trading halt whilst it launched a bookbuild process to facilitate the sale of a significant combined stake in the company by two existing shareholders.

Former CEO Chris Heaslip was selling 41.67 million shares and Executive Director Chris Fowler was selling 13.01 million shares.

These sales would reduce Mr Heaslip’s stake from 4% to 0.20% (which will be held by the Mission 316 Foundation) and Mr Fowler’s stake from 2.4% to 1.2%.

According to yesterday’s update, the sell down was fully underwritten at a floor price of NZ$1.75 per share. This represented a 7.4% discount to the last closing price of NZ$1.89 on 14 December.

What happened with the bookbuild?

This morning Pushpay revealed that the bookbuild was completed successfully.

According to the release, the 54.68 million shares were ultimately sold for NZ$1.79 per share, which was higher than the floor price and a discount of 5.3% to its last close price.

Pushpay advised that the book was oversubscribed and well supported, attracting bids from 22 institutional investors across New Zealand, Australia, Canada and the US. There was also strong participation from retail investors.

Pushpay’s CEO, Bruce Gordon, commented: “We are pleased to see the continued strong support for Pushpay in the market. The transaction attracted significant interest from both our existing and a number of new high-quality institutional investors.”

“The successful completion of this transaction further demonstrates that our value proposition and strategy to become the preferred provider of mission critical software to the US faith sector continues to resonate with investors,” he concluded.

FY 2021 guidance.

In case you missed it, yesterday the company also confirmed that it is on track to achieve its EBITDAF guidance of between US$54 million and US$58 million for the 12 months ending 31 March.

This represents a 116% to 132% increase, respectively, on FY 2020’s operating earnings of US$25.1 million.

However, management has warned that there are uncertainties and impacts surrounding COVID-19 and the broader US economic environment that remain.

More reading

• 3 exciting ASX tech shares to buy in 2021
• ASX 200 falls on Tuesday
• Top ASX shares to buy in 2021
• Why the Pushpay (ASX:PPH) share price is in a trading halt
• These are 10 of the best performing ASX tech shares of 2020 so far

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of PUSHPAY FPO NZX. The Motley Fool Australia has recommended PUSHPAY FPO NZX. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why the Pushpay (ASX:PPH) share price is tumbling lower today appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3noNOZg

In morning trade the Resolute Mining Limited (ASX: RSG) share price is charging higher.

At the time of writing, the gold miner’s shares are up 7.5% to 78 cents.

Why is the Resolute share price charging higher?

There have been a couple of catalysts for the solid rise in the Resolute share price on Wednesday.

The first is a rebound in the gold price overnight. According to CNBC, the price of the precious metal has risen 1.4% to US$1,857.50 an ounce. This was driven by optimism that major COVID stimulus is coming in the United States.

In addition to this, an announcement released yesterday evening by Resolute appears to have gone down well with investors.

What did Resolute announce?

Resolute has announced a binding agreement to sell its Bibiani Gold Mine in Ghana to China’s Chifeng Jilong Gold Mining Co.

According to the release, the two parties have agreed a total cash consideration of US$105 million. This comprises a US$5 million deposit on the signing of the agreement and US$100 million on completion.

The latter is expected by March 2021, subject to the satisfaction of government approvals and other conditions.

Resolute’s interim Chief Executive Officer, Stuart Gale, commented: “Resolute is proud of its contribution to Ghana and pleased that our investments at Bibiani in exploration, feasibility studies, and community support will provide a strong base for future success and value creation. I am confident that Resolute’s positive legacy in Ghana, and the interests of all stakeholders in Bibiani, will be protected and enhanced under Chifeng’s ownership.”

Chifeng’s Executive Chairman, Wang Jianhua, believes the operation fits well with its strategic focus.

He explained: “The transaction is consistent with our strategic focus on our core operating assets together with balance sheet improvement. We are delighted to have secured such a significant gold mining asset in the current market. Resolute has defined an exciting future for Bibiani as a high margin, long life underground gold mining operation. Chifeng will immediately invest the required capital, and provide the necessary expertise, to recommission Bibiani as an operating gold mine in the shortest possible timeframe.”

What’s next?

Resolute has agreed not to participate in any discussions for competing offers for Bibiani. It is also required to notify Chifeng if any superior proposal is received for Bibiani, following which Chifeng has 20 business days to match the offer.

If Chifeng does not match the offer, either Chifeng or Resolute may terminate the agreement, upon which a break fee of US$10 million will be payable by Resolute. The break fee is also payable by Resolute if Chifeng terminates the agreement due to a breach of its obligations under the agreement.

More reading

• Why Kathmandu, Resolute, Select Harvests, & Treasury Wine Estates are dropping lower

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why the Resolute Mining (ASX:RSG) share price is charging higher today appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/2WlbUbw

ASX bank dividends are back in focus after our banking regulator removed the caps on bank distributions.

This is a win for banking bulls who believe that the unshackling of dividends will help the sector catch up to the S&P/ASX 200 Index (Index:^AXJO) in 2021.

The question many will be asking is how much can ASX banks now afford to pay as we emerge from the COVID‐19 economic mayhem?

ASX banks can sustain a 10% ROE and 70% payout

The Australian Prudential Regulation Authority (APRA) no longer requires banks to limit payout ratios at under 50%. Prudence is still expected of them in respect to bank dividends, of course.

Goldman Sachs has put on its thinking cap and worked out that ASX banks can sustainably pay without upsetting APRA.

The broker believes the sector can sustain an average return on equity (ROE) of around 10%, which would support a dividend payout ratio of 70% while keeping the CET1 ratio at more than 10%.

ASX bank with the best dividend yield

“We note that our FY22E sector dividend forecast supports an average nominal yield of >5%, while the gap between the sector’s dividend yield grossed up for franking credits and the 10-year bond rate is still trading at more than one standard deviation cheap,” said Goldman.

But the ASX bank with the best dividend yield for the current financial year is the Westpac Banking Corp (ASX: WBC) share price.

The broker is tipping the bank to pay a full year dividend of 97 cents a share, up from the 31 cents it paid in FY20.

Franking is cream on the cake

Investors won’t need to wait till FY22 to get a circa 5% yield from the Westpac share price. The bank is already sitting on a yield of 4.9% based on yesterday’s closing price, based on Goldman’s estimates.

If you included franking credits, the yield jumps to nearly 7%. Not bad in this near zero interest rate environment!

Another ASX financial with a high dividend yield

The only large cap ASX financial stock that can match Westpac on yield is the Suncorp Group Ltd (ASX: SUN) share price.

Suncorp may not technically be a bank, but it’s on a yield of 5.2% before franking, according to Goldman.

The broker is recommending investors buy the Westpac share price and Suncorp share price. But the bank that it’s really bullish on is the National Australia Bank Ltd. (ASX: NAB) share price.

Goldman rates the NAB share price as a “conviction buy”. NAB is the only bank to be included on this list.

More reading

• Why the Beacon Lighting (ASX:BLX) share price is on watch today
• Here’s how ASX 200 bank shares have performed in 2020 so far
• Why ASX banks are licking their lips right now
• 5 things to watch on the ASX 200 on Wednesday
• ASX 200 falls on Tuesday

The post The ASX bank with the best dividend yield under APRA’s new guidelines appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/37roxYZ